Healthcare · Biotechnology
Price
$22.87
Market Cap
$30.7M
Employees
29
Beta
-0.23
Avg Volume
55,453
CEO
Anand Parikh
Business Description
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
Business History
Price Overview
Last updated: Jun 27, 2026 8:57am (just now)$22.87
-1.80 (-7.30%)
Day Range
$22.87 – $26.99
52-Week Range
$6.33 – $36.76
50-Day MA
$21.52
200-Day MA
$16.79
Volume
145,706.00
Analyst Price Targets
Low
$50.00
Consensus
$55.67
High
$60.00
(5 analysts)
Share Structure
Outstanding
1,341,942.00
Float
246,466.07
Free Float
0.0%
Very low free float
— 0.0% of shares trade freely, ~100% held by insiders/institutions
Thinly traded — expect wider bid-ask spreads and sharp price swings on modest volume. Institutional investors may avoid due to liquidity constraints.
Small absolute float (0.2M shares) — even with a decent free float %, volume can be thin. Check average daily volume before sizing a position.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-1.37
Stock Price: $22.87
EPS (Diluted): -16.72
EPS (Diluted): -16.72
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
0.72
Stock Price: $22.87
Total Equity: $18.59M
Shares: 1,260,772
Total Equity: $18.59M
Shares: 1,260,772
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
0.65
Market Cap: $30.69M
Total Debt: $59,000
Cash: $8.67M
EBITDA: -$20.91M
Total Debt: $59,000
Cash: $8.67M
EBITDA: -$20.91M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$6.3M
Market Cap: $30.69M
Total Debt: $59,000
Cash: $8.67M
Total Debt: $59,000
Cash: $8.67M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
0.00
Stock Price: $22.87
Revenue: $0.00
Shares: 1,260,772
Revenue: $0.00
Shares: 1,260,772
EV/Sales (Total value vs revenue — works when P/E can't)
API0.00
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
0.0%
Gross Profit: $0.00
Revenue: $0.00
Revenue: $0.00
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
0.0%
Operating Income: -$22.29M
Revenue: $0.00
Revenue: $0.00
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
0.0%
Net Income: -$21.09M
Revenue: $0.00
Revenue: $0.00
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-283.7%
Net Income: -$21.09M
Total Equity: $18.59M
Total Equity: $18.59M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-96.6%
Operating Income: -$22.29M
Tax Rate: 0.0%
Equity: $18.59M
Total Debt: $59,000
Cash: $8.67M
Tax Rate: 0.0%
Equity: $18.59M
Total Debt: $59,000
Cash: $8.67M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
5.06
Current Assets: $21.51M
Current Liabilities: $4.25M
Current Liabilities: $4.25M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $59,000
Total Debt: $59,000
Total Equity: $18.59M
Long-Term Debt: $59,000
Total Debt: $59,000
Total Equity: $18.59M
Rev/Share (Top-line per share)
Revenue / Shares Outstanding
—
Revenue: $0.00
Shares: 1,260,772
Shares: 1,260,772
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$14.75
Total Equity: $18.59M
Shares: 1,260,772
Shares: 1,260,772
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-16.24
Operating CF: -$20.45M
CapEx: -$16,000
Shares: 1,260,772
CapEx: -$16,000
Shares: 1,260,772
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $22.87
Stock Price: $22.87
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$21.09M
Net Income: -$21.09M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares FTH against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 22, 2026 6:30pm (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $685,000 | $1.8M | $571,000 | $551,000 | $0 |
| Gross Profit | $-685,000 | -$1.8M | $-571,000 | $-551,000 | $0 |
| Operating Expenses | $36.8M | $47.3M | $36.5M | $31.1M | $22.3M |
| Operating Income | -$37.5M | -$49.1M | -$37.1M | -$31.7M | -$22.3M |
| Net Income | -$36.8M | -$48.6M | -$34.1M | -$30.2M | -$21.1M |
| EBITDA | -$35.4M | -$46.6M | -$33.4M | -$29.5M | -$20.9M |
| EPS | $-1.33 | $-1.58 | $-1.22 | $-1.20 | $-16.72 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 22, 2026 6:30pm (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $7.2M | $17.8M | $13.0M | $10.0M | $8.7M |
| Total Current Assets | $148.5M | $108.6M | $67.3M | $41.9M | $21.5M |
| Total Assets | $153.2M | $118.4M | $74.4M | $45.4M | $22.9M |
| Current Liabilities | $4.9M | $9.1M | $5.6M | $5.4M | $4.3M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $59,000 |
| Total Liabilities | $6.7M | $15.0M | $9.5M | $7.0M | $4.3M |
| Total Equity | $146.5M | $103.4M | $64.9M | $38.4M | $18.6M |
| Retained Earnings | -$149.2M | -$197.8M | -$231.9M | -$262.1M | -$283.1M |
Cash Flow (Annual)
Last updated: Jun 24, 2026 1:29pm (2d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$30.3M | -$39.0M | -$32.0M | -$24.7M | -$20.5M |
| Capital Expenditure | -$2.0M | $-321,000 | $-180,000 | $-146,000 | $-16,000 |
| Free Cash Flow | -$32.3M | -$39.3M | -$32.2M | -$24.8M | -$20.5M |
| Acquisitions (net) | $318,000 | $15,000 | $166,000 | $0 | $250,000 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | -$10.4M | $0 | $-1,000 |
| Net Change in Cash | -$9.4M | $10.6M | -$4.8M | -$3.0M | -$1.3M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 8:57am (just now)| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 |
$16.8M $16.8M – $16.8M
|
| EBITDA | $0 | $0 | $0 | $0 |
| Net Income |
-$183.2M -$183.2M – -$183.2M
|
-$114.2M -$203.0M – -$25.3M
|
-$11.2M -$17.5M – -$5.0M
|
-$8.0M -$12.2M – -$3.8M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 22, 2026 6:30pm (4d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | — | — | — | — |
| Gross Profit Growth | -163.9% | +68.4% | +3.5% | +100.0% |
| Operating Income Growth | -31.0% | +24.5% | +14.6% | +29.6% |
| Net Income Growth | -32.1% | +29.8% | +11.6% | +30.1% |
| EBITDA Growth | -31.4% | +28.3% | +11.6% | +29.1% |
Insider Trading (Recent)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-26 | STEPHENSON BRIAN C | P-Purchase | 100.00 | $26.39 | $2,639 |
| 2026-06-26 | STEPHENSON BRIAN C | P-Purchase | 1,358.00 | $25.55 | $34,697 |
| 2026-06-26 | STEPHENSON BRIAN C | P-Purchase | 4,212.00 | $24.90 | $104,879 |
| 2026-06-26 | STEPHENSON BRIAN C | P-Purchase | 580.00 | $23.61 | $13,694 |
| 2026-06-24 | STEPHENSON BRIAN C | P-Purchase | 100.00 | $27.77 | $2,777 |
| 2026-06-24 | STEPHENSON BRIAN C | P-Purchase | 3,400.00 | $26.98 | $91,732 |
| 2026-06-24 | STEPHENSON BRIAN C | P-Purchase | 3,000.00 | $25.98 | $77,940 |
| 2026-06-24 | STEPHENSON BRIAN C | P-Purchase | 2,891.00 | $25.22 | $72,911 |
| 2026-06-23 | STEPHENSON BRIAN C | P-Purchase | 425.00 | $25.91 | $11,012 |
| 2026-06-23 | STEPHENSON BRIAN C | P-Purchase | 1,969.00 | $24.84 | $48,910 |
| 2026-06-23 | STEPHENSON BRIAN C | P-Purchase | 6,836.00 | $24.12 | $164,884 |
| 2026-06-22 | STEPHENSON BRIAN C | P-Purchase | 356.00 | $23.95 | $8,526 |
| 2026-06-22 | STEPHENSON BRIAN C | P-Purchase | 3,329.00 | $23.28 | $77,499 |
| 2026-06-22 | STEPHENSON BRIAN C | P-Purchase | 1,583.00 | $22.40 | $35,459 |
| 2026-06-22 | STEPHENSON BRIAN C | P-Purchase | 1,118.00 | $20.82 | $23,277 |
| 2026-06-22 | STEPHENSON BRIAN C | P-Purchase | 1,797.00 | $20.23 | $36,353 |
| 2026-06-22 | Parikh Anand Kiran | M-Exempt | 8,213.00 | $1.16 | $9,527 |
| 2026-06-22 | Parikh Anand Kiran | M-Exempt | 45,252.00 | $1.16 | $52,492 |
| 2026-06-22 | Parikh Anand Kiran | P-Purchase | 2,806.00 | $19.76 | $55,447 |
| 2026-06-22 | Parikh Anand Kiran | M-Exempt | 45,252.00 | $1.16 | $52,492 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for FTH — it's generated by the pipeline (
market-narrative step).
No community reviews yet for FTH.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30